File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Hormonal methods for emergency contraception

TitleHormonal methods for emergency contraception
Authors
KeywordsCyclo-oxygenase inhibitors
Hormonal emergency contraception
Levonorgestrel
Mifepristone
Ulipristal acetate
Issue Date3-Sep-2024
PublisherElsevier
Citation
Best Practice and Research: Clinical Obstetrics and Gynaecology, 2024, v. 97 How to Cite?
Abstract

The World Health Organization includes oral emergency contraception (EC) in the list of essential medicines. Ulipristal acetate (UPA) and levonorgestrel (LNG) are the recommended oral methods. UPA has superior efficacy and a comparable side effect profile compared with LNG. Both work by inhibiting or delaying ovulation, so that sperm present in the reproductive tract will have lost their fertilising ability by the time the oocyte is eventually released. Neither LNG nor UPA at the EC doses have significant effects on the endometrium and are unable to prevent implantation. Mifepristone can also be used for EC but its availability is limited to few countries. LNG is less effective in women with a body mass index over 26 kg/m2 or weight over 70 kg. Hormonal contraception can be quickstarted immediately following LNG, or five days following UPA. LNG-releasing intrauterine devices and cyclo-oxygenase inhibitors are promising options for EC to be further studied.


Persistent Identifierhttp://hdl.handle.net/10722/350510
ISSN
2023 Impact Factor: 3.9
2023 SCImago Journal Rankings: 1.532

 

DC FieldValueLanguage
dc.contributor.authorLi, Raymond Hang Wun-
dc.contributor.authorLo, Sue Seen Tsing-
dc.contributor.authorCameron, Sharon Tracey-
dc.date.accessioned2024-10-29T00:31:58Z-
dc.date.available2024-10-29T00:31:58Z-
dc.date.issued2024-09-03-
dc.identifier.citationBest Practice and Research: Clinical Obstetrics and Gynaecology, 2024, v. 97-
dc.identifier.issn1521-6934-
dc.identifier.urihttp://hdl.handle.net/10722/350510-
dc.description.abstract<p>The World Health Organization includes oral emergency contraception (EC) in the list of essential medicines. Ulipristal acetate (UPA) and levonorgestrel (LNG) are the recommended oral methods. UPA has superior efficacy and a comparable side effect profile compared with LNG. Both work by inhibiting or delaying ovulation, so that sperm present in the reproductive tract will have lost their fertilising ability by the time the oocyte is eventually released. Neither LNG nor UPA at the EC doses have significant effects on the endometrium and are unable to prevent implantation. Mifepristone can also be used for EC but its availability is limited to few countries. LNG is less effective in women with a body mass index over 26 kg/m<sup>2</sup> or weight over 70 kg. Hormonal contraception can be quickstarted immediately following LNG, or five days following UPA. LNG-releasing intrauterine devices and cyclo-oxygenase inhibitors are promising options for EC to be further studied.<br></p>-
dc.languageeng-
dc.publisherElsevier-
dc.relation.ispartofBest Practice and Research: Clinical Obstetrics and Gynaecology-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectCyclo-oxygenase inhibitors-
dc.subjectHormonal emergency contraception-
dc.subjectLevonorgestrel-
dc.subjectMifepristone-
dc.subjectUlipristal acetate-
dc.titleHormonal methods for emergency contraception-
dc.typeArticle-
dc.identifier.doi10.1016/j.bpobgyn.2024.102550-
dc.identifier.scopuseid_2-s2.0-85203144080-
dc.identifier.volume97-
dc.identifier.issnl1521-6934-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats